Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-16 Sale | 2024-09-17 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 192 | $36.21 | $6,952 | 38,141 (Direct) | View |
| 2024-09-03 Sale | 2024-09-04 4:07 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 550 | $39.49 | $21,720 | 38,333 (Direct) | View |
| 2024-03-15 Sale | 2024-03-18 4:19 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 184 | $56.46 | $10,389 | 38,883 (Direct) | View |
| 2024-01-22 Sale | 2024-01-23 6:00 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 1,061 | $65 | $68,961 | 39,067 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 4:45 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 864 | $66.81 | $57,723 | 52,214 (Direct) | View |
| 2023-10-23 Sale | 2023-10-24 4:20 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 132 | $46.04 | $6,077 | 32,680 (Direct) | View |
| 2023-08-31 Sale | 2023-09-01 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 551 | $41.23 | $22,716 | 30,312 (Direct) | View |
| 2021-03-05 Sale | 2021-03-09 06:54 am | Radius Health Inc. | RDUS | Chopas James George Principal Finance Accounting | 370 | $20.88 | $7,726 | 6,701 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-16 Option Award | 2024-01-17 4:45 pm | N/A 2034-01-15 | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 12,086 | $66.3 | 52,214 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:45 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 8,312 | $0 | 52,214 (Direct) | View |
| 2023-09-14 Option Award | 2023-09-18 4:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 2,500 | $0 | 32,812 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 06:44 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 334 | $58.5 | 36,600 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-22 06:44 am | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 9,781 | $0 | 36,600 (Direct) | View |
| 2023-01-20 Tax Withholding | 2023-01-24 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 919 | $52.05 | 27,153 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:26 pm | N/A 2033-01-11 | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 15,114 | $52.66 | 43,186 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:26 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 9,621 | $0 | 43,186 (Direct) | View |
| 2022-10-20 Tax Withholding | 2022-10-24 5:09 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 130 | $58 | 18,451 (Direct) | View |
| 2022-08-30 Tax Withholding | 2022-08-31 4:26 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 558 | $58.84 | 18,581 (Direct) | View |
| 2022-01-21 Option Award(A) | 2022-02-07 8:06 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 25,773 | $0 | 34,255 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:36 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 16,866 | $0 | 25,348 (Direct) | View |
| 2021-10-20 Option Award | 2021-10-27 4:31 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 882 | $0 | 8,482 (Direct) | View |
| 2021-08-30 Option Award | 2021-09-01 4:34 pm | N/A 2031-08-29 | Apellis Pharmaceuticals Inc. | APLS | Chopas James George See Remarks | 29,350 | $0 | 29,350 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-23 6:07 pm | N/A 2031-02-22 | Radius Health Inc. | RDUS | Chopas James George Principal Finance Accounting | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-01-20 Option Award | 2021-01-21 6:18 pm | N/A 2031-01-20 | Radius Health Inc. | RDUS | Chopas James George Principal Finance Accounting | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2020-12-18 08:40 am | N/A N/A | Radius Health Inc. | RDUS | Chopas James George Principal Finance Accounting | 0 | $0 | 54,992 (Direct) | View |